Evidence map›Paper›PMID 30465689›Full record

ArticleJournal of the International AIDS Society2018

90-90-90 by 2020? Estimation and projection of the adult HIV epidemic and ART programme in Zimbabwe - 2017 to 2020.

Loveleen Bansi-Matharu, Valentina Cambiano, Tsitsi Apollo, Raymond Yekeye, Jeffrey Dirawo, Sithembile Musemburi, Calum Davey, Sue Napierala, Elizabeth Fearon, Amon Mpofu and 4 more

Abstract read
In one paragraph

Article in Journal of the International AIDS Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Loveleen Bansi-MatharuInstitute for Global Health, UCL, London, UK.ORCID 0000-0002-0233-7622
Valentina CambianoInstitute for Global Health, UCL, London, UK.ORCID 0000-0003-0700-105X
Tsitsi ApolloDepartment of HIV/AIDS and STIs, Ministry of Health and Childcare, Harare, Zimbabwe.
Raymond YekeyeZimbabwe National AIDS Council, Harare, Zimbabwe.
Jeffrey DirawoCentre for Sexual Health, HIV/AIDS Research Zimbabwe, Harare, Zimbabwe.
Sithembile MusemburiCentre for Sexual Health, HIV/AIDS Research Zimbabwe, Harare, Zimbabwe.
Calum DaveyFaculty of Public Health and Policy, London School of Hygiene and Tropical Medicine (LSHTM), London, UK.
Sue NapieralaRTI International, San Francisco, CA, USA.
Elizabeth FearonDepartment of Social and Environmental Health Research, London School of Hygiene & Tropical Medicine, London, UK.ORCID 0000-0001-5574-251X
Amon MpofuZimbabwe National AIDS Council, Harare, Zimbabwe.
Owen MugurungiTB and AIDS Unit, Zimbabwe Ministry of Health, Harare, Zimbabwe.
James R HargreavesDepartment of Social and Environmental Health Research, London School of Hygiene & Tropical Medicine, London, UK.
Frances M CowanCentre for Sexual Health, HIV/AIDS Research Zimbabwe, Harare, Zimbabwe.
Andrew N PhillipsInstitute for Global Health, UCL, London, UK.

Funding

HIV Prevention among Young Female Sex Workers: an Implementation Research ApproachK01MH110316 · NIMH · RESEARCH TRIANGLE INSTITUTE · PI NAPIERALA, SUE · 2016 to 2019
$753k
NIMH NIH HHS K01 MH110316
6 · The paper itself

Abstract

introductionThe 90-90-90 targets set by the United Nations aspire to 73% of people living with HIV (PLHIV) being virally suppressed by 2020. Using the HIV Synthesis Model, we aim to mimic the epidemic in Zimbabwe and make projections to assess whether Zimbabwe is on track to meet the 90-90-90 targets and assess whether recently proposed UNAIDS HIV transition metrics are likely to be met.

methodsWe used an approximate Bayesian computation approach to identify model parameter values which result in model outputs consistent with observed data, evaluated using a calibration score. These parameter values were then used to make projections to 2020 to compare with the 90-90-90 targets and other key indicators. We also calculated HIV transition metrics proposed by UNAIDS (percentage reduction in new HIV infections and AIDS-related mortality from 2010 to 2020, absolute rate of new infections and AIDS-related mortality, incidence-mortality ratio and incidence-prevalence ratios).

resultsAfter calibration, there was general agreement between modelled and observed data. The median predicted outcomes in 2020 were: proportion of PLHIV (aged 15 to 65) diagnosed 0.91 (90% uncertainty range 0.87, 0.94) (0.84 men, 0.95 women); of those diagnosed, proportion on treatment 0.92 (0.90, 0.93); of those receiving treatment, proportion with viral suppression 0.86 (0.81, 0.91). This results in 72% of PLHIV having viral suppression in 2020. We estimated a percentage reduction of 36.5% (13.7% increase to 67.4% reduction) in new infections from 2010 to 2020, and of 30.4% (9.7% increase to 56.6% reduction) in AIDS-related mortality (UNAIDS target 75%). The modelled absolute rates of HIV incidence and AIDS-related mortality in 2020 were 5.48 (2.26, 9.24) and 1.93 (1.31, 2.71) per 1000 person-years respectively. The modelled incidence-mortality ratio and incidence-prevalence ratios in 2020 were 1.05 (0.46, 1.66) and 0.009 (0.004, 0.013) respectively.

conclusionsOur model was able to produce outputs that are simultaneously consistent with an array of observed data and predicted that while the 90-90-90 targets are within reach in Zimbabwe, increased efforts are required in diagnosing men in particular. Calculation of the HIV transition metrics suggest increased efforts are needed to bring the HIV epidemic under control.

Indexed as

AdolescentAdultAgedAnti-HIV AgentsBayes TheoremCD4 Lymphocyte CountEpidemicsFemaleHIV InfectionsHumansIncidenceMaleMass ScreeningMiddle AgedModels, BiologicalPrevalenceAnti-HIV AgentsHIV care continuumpublic healthtestingtreatmentviral suppression

Identifiers

PMID30465689
PMCPMC6250855

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.